Friday, 16 October 2026European Markets

BIC And REMY COINTREAU Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(vianews) - bic (bb.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer defensive sector.

financial asset price forward dividend yield return on equity
bic (bb.pa) €60.40 4.24% 11.06%
remy cointreau (rco.pa) €115.80 1.76% 17.18%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. bic (bb.pa)

4.24% forward dividend yield and 11.06% return on equity

société bic sa manufactures and sells stationery, lighter, shaver, and other products worldwide. it offers ball and coloring felt pens, gel ink pens, markers, sticky notes, leads, whiteboards, and correction tapes, as well as graphite, coloring, mechanical, and other pencils; reusable notebooks, digital slates, and smart pens; art and craft kits; permanent and temporary tattoo markers; and pen and pencil refills. the company also provides refillable shavers and razors; and pocket, utility, and decorated lighters. in addition, it sells batteries and shaving preps; and advertising and promotional products. further, the company is involved in the provision of delivery services; production of industrial equipment; and manufacture and distribution of it solutions and consumer products, as well as in real estate and insurance activities. it markets its products primarily under the bic, bic kids, cello, lucky, rocketbook, tipp-ex, bic wite-out, tattly, ami, djeep, inkbox, bic soleil, bic evolution, and bodymark brands through a range of channels, including retail mass-market distributors, traditional stores, and office product stationers, as well as an e-commerce site. the company was founded in 1944 and is headquartered in clichy, france.

earnings per share

as for profitability, bic has a trailing twelve months eps of €4.36.

pe ratio

bic has a trailing twelve months price to earnings ratio of 13.85. meaning, the purchaser of the share is investing €13.85 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.06%.

revenue growth

year-on-year quarterly revenue growth declined by 3.4%, now sitting on 2.26b for the twelve trailing months.

more news about bic.

2. remy cointreau (rco.pa)

1.76% forward dividend yield and 17.18% return on equity

rémy cointreau sa, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. the company operates through rémy martin, liqueurs & spirits, and partner brands segments. it offers liqueurs, brandy, gin, single malt whisky, rum, wine, and champagne primarily under the cointreau, metaxa, st-rémy, mount gay, bruichladdich, port charlotte, octomore, the botanist, westland, louis xiii, and domaine des hautes glaces brands. the company operates in europe, the middle east, africa, the americas, asia, australia, and new zealand. rémy cointreau sa was founded in 1724 and is headquartered in cognac, france.

earnings per share

as for profitability, remy cointreau has a trailing twelve months eps of €5.7.

pe ratio

remy cointreau has a trailing twelve months price to earnings ratio of 20.32. meaning, the purchaser of the share is investing €20.32 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.18%.

volatility

remy cointreau's last week, last month's, and last quarter's current intraday variation average was 2.54%, 0.19%, and 1.74%.

remy cointreau's highest amplitude of average volatility was 2.54% (last week), 2.36% (last month), and 1.74% (last quarter).

yearly top and bottom value

remy cointreau's stock is valued at €115.80 at 21:30 est, way under its 52-week high of €180.50 and way higher than its 52-week low of €102.50.

moving average

remy cointreau's worth is below its 50-day moving average of €123.18 and way under its 200-day moving average of €149.20.

revenue growth

year-on-year quarterly revenue growth grew by 2.1%, now sitting on 1.55b for the twelve trailing months.

more news about remy cointreau.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com